29 | Proteins (Proteins, Gene)FDA Link
01/2022
-
02/2004 |
18 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022
-
10/2007 |
15 | Biological ProductsIBA
12/2021
-
05/2007 |
11 | Peptides (Polypeptides)IBA
09/2022
-
06/2008 |
9 | Biomarkers (Surrogate Marker)IBA
01/2022
-
06/2018 |
9 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021
-
11/2014 |
8 | CytokinesIBA
01/2022
-
08/2011 |
8 | IntegrinsIBA
01/2022
-
07/2013 |
7 | VaccinesIBA
01/2022
-
05/2012 |
7 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2020
-
11/2014 |
6 | Anti-Bacterial Agents (Antibiotics)IBA
01/2021
-
01/2017 |
6 | Pharmaceutical PreparationsIBA
10/2020
-
04/2004 |
6 | Neutralizing AntibodiesIBA
10/2020
-
02/2011 |
6 | Small Interfering RNA (siRNA)IBA
01/2020
-
12/2012 |
6 | ErbB Receptors (EGF Receptor)IBA
01/2017
-
12/2007 |
5 | AntibodiesIBA
09/2022
-
01/2016 |
5 | TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2022
-
01/2016 |
5 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
-
01/2006 |
5 | Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2017
-
03/2010 |
4 | RNA (Ribonucleic Acid)IBA
09/2021
-
04/2018 |
4 | Monoclonal AntibodiesIBA
07/2021
-
01/2006 |
4 | Messenger RNA (mRNA)IBA
03/2021
-
03/2015 |
4 | Tyrosine Kinase InhibitorsIBA
02/2021
-
07/2015 |
4 | Therapeutic UsesIBA
01/2021
-
01/2006 |
4 | Immunoglobulin G (IgG)IBA
01/2020
-
01/2013 |
4 | Cadherins (E-Cadherin)IBA
10/2016
-
11/2014 |
3 | Radioisotopes (Radionuclides)IBA
10/2022
-
01/2019 |
3 | AntigensIBA
09/2022
-
09/2014 |
3 | 68Ga-FAPIIBA
01/2022
-
01/2021 |
3 | DNA (Deoxyribonucleic Acid)IBA
01/2022
-
10/2004 |
3 | Estrogen ReceptorsIBA
01/2022
-
01/2017 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
-
07/2015 |
3 | Immunoglobulins (Immunoglobulin)IBA
01/2022
-
11/2014 |
3 | 2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
11/2021
-
04/2017 |
3 | ImipenemFDA Link
01/2021
-
11/2019 |
3 | Immunoglobulin E (IgE)IBA
01/2021
-
01/2012 |
3 | Evans Blue (Blue, Evans)FDA Link
01/2020
-
01/2006 |
3 | CateninsIBA
01/2019
-
01/2011 |
3 | Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2014
-
08/2002 |
2 | Circular RNAIBA
02/2022
-
10/2020 |
2 | sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2022
-
01/2019 |
2 | Interleukin-6 (Interleukin 6)IBA
01/2022
-
02/2019 |
2 | Dextrans (Dextran)FDA Link
01/2022
-
01/2019 |
2 | FluorineIBA
01/2022
-
01/2021 |
2 | ORALIT (ORS)IBA
01/2022
-
09/2017 |
2 | Neuropilin-1IBA
01/2022
-
12/2014 |
2 | AntioxidantsIBA
01/2022
-
09/2016 |
2 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022
-
08/2009 |